This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

(2-Aminoethyl)phosphonic acid is an endogenous metabolite.

This is a Chinese Pharmacopoeia compound.

(2,4-Dihydroxyphenyl)acetonitrile is a natural product isolated and purified from the herbs of Diploclisia glaucescens.

(2,4-Dihydroxyphenyl)acetonitrile is a natural product isolated and purified from the herbs of Diploclisia glaucescens.

(2,4-Dihydroxyphenyl)acetonitrile is a natural product isolated and purified from the herbs of Diploclisia glaucescens.

(2,4-Dihydroxyphenyl)acetonitrile is a natural product isolated and purified from the herbs of Diploclisia glaucescens.

(2,4-Dihydroxyphenyl)acetonitrile is a natural product isolated and purified from the herbs of Diploclisia glaucescens.

(2,4-Dihydroxyphenyl)acetonitrile is a natural product isolated and purified from the herbs of Diploclisia glaucescens.

trans-trans-Muconic acid is a urinary metabolite of benzene and has been used as a biomarker of exposure to benzene in human.

2′,3′,5′-Tri-O-acetylinosine is an intermediate used for the synthesis of 6-substituted purine ribosides.

This is a Chinese Pharmacopoeia compound.

(2R,3R)-Butane-2,3-diol is an endogenous metabolite.

This is a Chinese Pharmacopoeia compound.

(2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl ditetradecanoate is an endogenous metabolite.

This is a Chinese Pharmacopoeia compound.

(2S,3R,4S,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride is an endogenous metabolite.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

(3R,4S)-Tofacitinib is an isomer of tofacitinib, an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

(3R,4S)-Tofacitinib is an isomer of tofacitinib, an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

(3S,4R)-Tofacitinib is an isomer of tofacitinib, which is an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

(3S,4R)-Tofacitinib is an isomer of tofacitinib, which is an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

(3S,4S)-Tofacitinib is an isomer of tofacitinib, an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

(3S,4S)-Tofacitinib is an isomer of tofacitinib, an inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.

This is a Chinese Pharmacopoeia compound.

(9Z,11E)-Tetradecadien-1-yl acetate is the main component of the sex pheromone of female Spodoptera littoralis.

(9Z,11E)-Tetradecadien-1-yl acetate is the main component of the sex pheromone of female Spodoptera littoralis.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

This is a Chinese Pharmacopoeia compound.

(E)-3-Acetoxy-5-methoxystilbene is a natural product isolated and purified from the herbs of Jatropha curcas.

This is a Chinese Pharmacopoeia compound.

(E)-3-Hydroxy-5-methoxystilbene possesses inhibitory activity against several Gram-positive bacteria, including isolates of methicillin-resistant Staphylococcus aureus (MRSA), Mycobacterium bovis BCG, and avirulent Bacillusanthracis (Sterne strain), among others.

(E)-3PO is a small-molecule inhibitor of the PFKFB3 isozyme, 3PO markedly attenuates the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines (IC50, 1.4-24 μM) which target: PFKFB3 isozyme. 3PO inhibits recombinant PFKFB3 activity, suppresses glucose uptake, and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+, and NADH in vitro.

(E)-3PO is a small-molecule inhibitor of the PFKFB3 isozyme, 3PO markedly attenuates the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines (IC50, 1.4-24 μM) which target: PFKFB3 isozyme. 3PO inhibits recombinant PFKFB3 activity, suppresses glucose uptake, and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+, and NADH in vitro.

(E)-3PO is a small-molecule inhibitor of the PFKFB3 isozyme, 3PO markedly attenuates the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines (IC50, 1.4-24 μM) which target: PFKFB3 isozyme. 3PO inhibits recombinant PFKFB3 activity, suppresses glucose uptake, and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD+, and NADH in vitro.